IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 40 filers reported holding IKENA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $894 | -32.6% | 206,545 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $1,326 | +94.1% | 202,202 | +2.1% | 0.00% | – |
| Q1 2023 | $683 | +28.6% | 198,041 | -0.7% | 0.00% | – |
| Q4 2022 | $531 | -99.9% | 199,403 | -0.9% | 0.00% | -100.0% |
| Q3 2022 | $714,000 | -19.9% | 201,227 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $891,000 | -29.0% | 201,095 | -2.2% | 0.00% | 0.0% |
| Q1 2022 | $1,255,000 | – | 205,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $63,538,000 | 6.01% |
| CHI Advisors LLC | 814,756 | $23,017,000 | 4.61% |
| Octagon Capital Advisors LP | 400,000 | $11,300,000 | 4.26% |
| BVF INC/IL | 1,599,658 | $45,190,000 | 1.69% |
| Logos Global Management LP | 419,853 | $11,861,000 | 1.16% |
| Orbimed Advisors | 2,933,941 | $82,884,000 | 0.78% |
| Artal Group S.A. | 1,549,513 | $43,774,000 | 0.77% |
| HealthCor Management, L.P. | 341,212 | $9,639,000 | 0.34% |
| RA Capital Management | 750,000 | $21,188,000 | 0.32% |
| Nantahala Capital Management | 325,000 | $9,181,000 | 0.27% |